Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.

Molecular pharmaceutics - 7 Jun 2021

Sajid Muhammad Imran, Moazzam Muhammad, Cho Yeseom, Kato Shun, Xu Ava, Way J J, Lohan Sandeep, Tiwari Rakesh K

Abstract excerpt

The ongoing pandemic of global concern has killed about three million humans and affected around 151 million people worldwide, as of April 30, 2021. Although recently approved vaccines for COVID-19 are engendering hope, finding new ways to cure the viral pandemic is still a quest for researchers worldwide. Major pandemics in history have been of viral origin, such as SARS, MERS, H1NI, Spanish flu, and so on. A...

Topics

Join the communities discussing this publication.

Clinical Trials as Topic
COVID-19 Drug Treatment
Drug Approval
Drug Evaluation, Preclinical
History, 20th Century

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

History, 21st Century

Patents as Topic

Source

Identifiers

PMID: 33945284
DOI: 10.1021/acs.molpharmaceut.0c01239

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.PMID 33945284Read ↗

The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses InfectionSemantic proximity Read ↗

Design of advanced siRNA therapeutics for the treatment of COVID-19Semantic proximity Read ↗

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIVSemantic proximity Read ↗

Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsSemantic proximity Read ↗

In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

Design and Delivery of Therapeutic siRNAs: Application to MERS-CoronavirusSemantic proximity Read ↗

Prospects for RNAi Therapy of COVID-19Semantic proximity Read ↗

In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

Development and application of ribonucleic acid therapy strategies against COVID-19Semantic proximity Read ↗

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2Semantic proximity Read ↗

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based deliverySemantic proximity Read ↗

MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.